Skip to main navigation
Skip to search
Skip to main content
The Capital Region of Denmark's Research Portal Home
Help & FAQ
Dansk
English
Home
Hospitals/departments
Researchers
Research output
Activities
Prizes
Search by expertise, name or affiliation
Thomas Landkildehus Lisle
Herlev and Gentofte Hospital
,
Center for Cancer Immune Therapy (CCIT)
2022
2023
Research activity per year
Overview
Fingerprint
Network
Research output
(5)
Similar Profiles
(12)
If you made any changes in Pure these will be visible here soon.
Fingerprint
Dive into the research topics where Thomas Landkildehus Lisle is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Subunit Vaccines
100%
Arginase
89%
T-Lymphocytes
71%
Ligands
58%
Calreticulin
57%
Cancer Vaccines
55%
Immunoglobulin Heavy Chains
53%
Vaccination
49%
Major Histocompatibility Complex
44%
B-Cell Chronic Lymphocytic Leukemia
43%
Transforming Growth Factors
43%
Regulatory T-Lymphocytes
43%
Pancreatic Neoplasms
39%
Neoplasms
35%
Immunity
33%
Vaccines
32%
Radiotherapy
28%
Clinical Trials
26%
Survival
22%
Peptides
22%
Epitopes
20%
Alleles
15%
Peptide Fragments
13%
Enzyme-Linked Immunospot Assay
11%
Therapeutics
9%
Janus Kinase 2
9%
Tumor Microenvironment
8%
Blood Cells
6%
montanide ISA 51
6%
Frameshift Mutation
6%
Interferon-gamma
5%
Vaccine Immunogenicity
5%
Tissue Donors
5%
Bone Marrow
5%
Gene Frequency
5%
